Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LSP floats new life sciences fund

This article was originally published in Scrip

Executive Summary

Life Science Partners has established a new fund to invest in publicly quoted life science companies, raising initially just over €35 million in an initial public offering on the NYSE Euronext Amsterdam. LSP Life Sciences Fund NV will be managed by the same team that has been responsible, on behalf of LSP Advisory BV, for advising on investments in small to medium-sized publicly listed life science companies made under an strategic advisory agreement with APG Investments in 2008. Since that time, LSP's investments in publicly listed stocks has generated a return of more than 150%.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC012736

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel